Alzheimer's disease and Parkinson's disease have multiple contributing factors but share the contribution of oxidative damage to the brain, affecting mitochondria, the parts of cells that make energy (and your brain requires a lot of energy)
Triple agonists are unimolecular peptide drugs that target GLP-1R, GIP receptor, and glucagone receptor, developed primarily for treating metabolic diseases (Knerr et al., 2022)
Recovering from a binge eating disorder involves a team effort
When to Reach Out to Your Clinician Contact your Nuri provider (or local clinician) right away if you notice: Persistent or severe nausea, vomiting, or abdominal pain Trouble keeping fluids down Rapid, unintended weight loss with marked weakness or dizziness Ongoing difficulty meeting even a minimal protein or calorie intake These are all signs that your plan may need to be adjusted, dose changes, schedule tweaks, or additional support, so you can continue safely
GLP-1, or glucagon-like peptide-1 and GIP, or gastric inhibitory polypeptide are dual therapy hormones that plays a role in appetite regulation and blood sugar management Dual therapy hormones help release insulin to control blood sugar after eating
Balick, Michael J